Rank | Gene Set | Z-score |
---|---|---|
1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.57455233 |
2 | L-phenylalanine catabolic process (GO:0006559) | 7.57455233 |
3 | L-phenylalanine metabolic process (GO:0006558) | 7.23348191 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.23348191 |
5 | aromatic amino acid family catabolic process (GO:0009074) | 6.68986816 |
6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.18519402 |
7 | tryptophan catabolic process (GO:0006569) | 5.93627220 |
8 | indole-containing compound catabolic process (GO:0042436) | 5.93627220 |
9 | indolalkylamine catabolic process (GO:0046218) | 5.93627220 |
10 | kynurenine metabolic process (GO:0070189) | 5.82597515 |
11 | bile acid biosynthetic process (GO:0006699) | 5.73542883 |
12 | tryptophan metabolic process (GO:0006568) | 5.63736998 |
13 | alpha-linolenic acid metabolic process (GO:0036109) | 5.60828375 |
14 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 5.59307850 |
15 | glyoxylate metabolic process (GO:0046487) | 5.52162620 |
16 | high-density lipoprotein particle remodeling (GO:0034375) | 5.43528808 |
17 | negative regulation of fibrinolysis (GO:0051918) | 5.30944605 |
18 | urea metabolic process (GO:0019627) | 5.26090160 |
19 | urea cycle (GO:0000050) | 5.26090160 |
20 | protein carboxylation (GO:0018214) | 5.24297018 |
21 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.24297018 |
22 | response to dietary excess (GO:0002021) | 5.16545892 |
23 | regulation of fibrinolysis (GO:0051917) | 5.14542164 |
24 | complement activation, alternative pathway (GO:0006957) | 5.10270096 |
25 | regulation of protein activation cascade (GO:2000257) | 5.04213529 |
26 | * endocrine pancreas development (GO:0031018) | 5.00274567 |
27 | sulfur amino acid catabolic process (GO:0000098) | 4.99149920 |
28 | bile acid metabolic process (GO:0008206) | 4.97453421 |
29 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 4.96523057 |
30 | glandular epithelial cell differentiation (GO:0002067) | 4.95097320 |
31 | regulation of cholesterol esterification (GO:0010872) | 4.88485453 |
32 | aromatic amino acid family metabolic process (GO:0009072) | 4.87932200 |
33 | cysteine metabolic process (GO:0006534) | 4.87135764 |
34 | nitrogen cycle metabolic process (GO:0071941) | 4.85157118 |
35 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.81122491 |
36 | serine family amino acid catabolic process (GO:0009071) | 4.76153150 |
37 | tyrosine metabolic process (GO:0006570) | 4.73362595 |
38 | regulation of triglyceride catabolic process (GO:0010896) | 4.71907879 |
39 | reverse cholesterol transport (GO:0043691) | 4.70301747 |
40 | regulation of complement activation (GO:0030449) | 4.69093438 |
41 | phospholipid efflux (GO:0033700) | 4.64654357 |
42 | acylglycerol homeostasis (GO:0055090) | 4.63545198 |
43 | triglyceride homeostasis (GO:0070328) | 4.63545198 |
44 | plasma lipoprotein particle remodeling (GO:0034369) | 4.63130343 |
45 | protein-lipid complex remodeling (GO:0034368) | 4.63130343 |
46 | macromolecular complex remodeling (GO:0034367) | 4.63130343 |
47 | lactate metabolic process (GO:0006089) | 4.56574499 |
48 | lysine metabolic process (GO:0006553) | 4.50384506 |
49 | lysine catabolic process (GO:0006554) | 4.50384506 |
50 | alpha-amino acid catabolic process (GO:1901606) | 4.47650781 |
51 | negative regulation of sterol transport (GO:0032372) | 4.47648049 |
52 | negative regulation of cholesterol transport (GO:0032375) | 4.47648049 |
53 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.47324771 |
54 | nitric oxide mediated signal transduction (GO:0007263) | 4.42738695 |
55 | coenzyme catabolic process (GO:0009109) | 4.40709811 |
56 | cellular ketone body metabolic process (GO:0046950) | 4.38418997 |
57 | homocysteine metabolic process (GO:0050667) | 4.37045492 |
58 | insulin secretion (GO:0030073) | 4.36909591 |
59 | type B pancreatic cell development (GO:0003323) | 4.35281738 |
60 | bile acid and bile salt transport (GO:0015721) | 4.35222239 |
61 | indolalkylamine metabolic process (GO:0006586) | 4.33060993 |
62 | amino-acid betaine metabolic process (GO:0006577) | 4.32119635 |
63 | plasma lipoprotein particle clearance (GO:0034381) | 4.23829121 |
64 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 4.22117934 |
65 | chemosensory behavior (GO:0007635) | 4.18405463 |
66 | regulation of glucokinase activity (GO:0033131) | 4.15556299 |
67 | regulation of hexokinase activity (GO:1903299) | 4.15556299 |
68 | cholesterol efflux (GO:0033344) | 4.13905191 |
69 | cellular amino acid catabolic process (GO:0009063) | 4.12839577 |
70 | imidazole-containing compound metabolic process (GO:0052803) | 4.10329397 |
71 | amine catabolic process (GO:0009310) | 4.09002052 |
72 | cellular biogenic amine catabolic process (GO:0042402) | 4.09002052 |
73 | glycine metabolic process (GO:0006544) | 4.05004888 |
74 | benzene-containing compound metabolic process (GO:0042537) | 4.03534700 |
75 | glutamate metabolic process (GO:0006536) | 4.00849617 |
76 | * positive regulation of glycolytic process (GO:0045821) | 3.99127271 |
77 | cellular glucuronidation (GO:0052695) | 3.96774735 |
78 | dendritic spine morphogenesis (GO:0060997) | 3.96528602 |
79 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.93402886 |
80 | plasma lipoprotein particle assembly (GO:0034377) | 3.91508944 |
81 | cellular modified amino acid catabolic process (GO:0042219) | 3.89679134 |
82 | fatty acid homeostasis (GO:0055089) | 3.87908720 |
83 | ethanol oxidation (GO:0006069) | 3.85888485 |
84 | drug catabolic process (GO:0042737) | 3.84840725 |
85 | synaptic vesicle maturation (GO:0016188) | 3.81378624 |
86 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.80552939 |
87 | serine family amino acid metabolic process (GO:0009069) | 3.80512622 |
88 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.79795495 |
89 | ketone body metabolic process (GO:1902224) | 3.78832029 |
90 | low-density lipoprotein particle remodeling (GO:0034374) | 3.78030530 |
91 | aldehyde catabolic process (GO:0046185) | 3.74428888 |
92 | negative regulation of lipase activity (GO:0060192) | 3.73923750 |
93 | intestinal cholesterol absorption (GO:0030299) | 3.73412950 |
94 | regulation of cholesterol homeostasis (GO:2000188) | 3.73261645 |
95 | fibrinolysis (GO:0042730) | 3.71674073 |
96 | phospholipid homeostasis (GO:0055091) | 3.70999367 |
97 | positive regulation of lipid catabolic process (GO:0050996) | 3.69789203 |
98 | arginine metabolic process (GO:0006525) | 3.69241893 |
99 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.69042076 |
100 | short-chain fatty acid metabolic process (GO:0046459) | 3.68993545 |
101 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.68702075 |
102 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.68702075 |
103 | cofactor catabolic process (GO:0051187) | 3.67884873 |
104 | carboxylic acid catabolic process (GO:0046395) | 3.67043112 |
105 | organic acid catabolic process (GO:0016054) | 3.67043112 |
106 | regulation of bile acid biosynthetic process (GO:0070857) | 3.65166469 |
107 | complement activation, classical pathway (GO:0006958) | 3.60512175 |
108 | cholesterol homeostasis (GO:0042632) | 3.60027554 |
109 | cytolysis (GO:0019835) | 3.59888672 |
110 | blood coagulation, intrinsic pathway (GO:0007597) | 3.59481283 |
111 | acetyl-CoA metabolic process (GO:0006084) | 3.57930995 |
112 | nodal signaling pathway (GO:0038092) | 3.57206999 |
113 | sterol homeostasis (GO:0055092) | 3.54124420 |
114 | glucuronate metabolic process (GO:0019585) | 3.53743240 |
115 | uronic acid metabolic process (GO:0006063) | 3.53743240 |
116 | complement activation (GO:0006956) | 3.51672423 |
117 | plasma lipoprotein particle organization (GO:0071827) | 3.51670781 |
118 | positive regulation of respiratory burst (GO:0060267) | 3.50722503 |
119 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.50526644 |
120 | protein activation cascade (GO:0072376) | 3.49994205 |
121 | positive regulation of growth hormone secretion (GO:0060124) | 3.48239668 |
122 | serine family amino acid biosynthetic process (GO:0009070) | 3.47521730 |
123 | monocarboxylic acid catabolic process (GO:0072329) | 3.46865352 |
124 | * positive regulation of peptide hormone secretion (GO:0090277) | 3.45333099 |
125 | negative regulation of acute inflammatory response (GO:0002674) | 3.42333569 |
126 | detection of calcium ion (GO:0005513) | 3.38595538 |
127 | * positive regulation of peptide secretion (GO:0002793) | 3.34323087 |
128 | * positive regulation of insulin secretion (GO:0032024) | 3.30020719 |
129 | regulation of feeding behavior (GO:0060259) | 3.29781759 |
130 | * regulation of insulin secretion (GO:0050796) | 3.28807917 |
131 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.24079145 |
132 | negative regulation of protein oligomerization (GO:0032460) | 3.23756662 |
133 | nucleobase catabolic process (GO:0046113) | 3.19792556 |
134 | presynaptic membrane assembly (GO:0097105) | 3.17078368 |
135 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.15368492 |
136 | negative regulation of hormone biosynthetic process (GO:0032353) | 3.15132198 |
137 | peptide hormone secretion (GO:0030072) | 3.14422830 |
138 | negative regulation of glycogen metabolic process (GO:0070874) | 3.06619670 |
139 | * regulation of peptide hormone secretion (GO:0090276) | 3.05897492 |
140 | peptide hormone processing (GO:0016486) | 3.05227901 |
141 | peptide secretion (GO:0002790) | 3.03833956 |
142 | positive regulation of neurotransmitter transport (GO:0051590) | 3.03154525 |
143 | presynaptic membrane organization (GO:0097090) | 3.01786118 |
144 | glandular epithelial cell development (GO:0002068) | 3.01253297 |
145 | epithelial cell fate commitment (GO:0072148) | 3.00832223 |
146 | * regulation of peptide secretion (GO:0002791) | 2.98809594 |
147 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.97210510 |
148 | norepinephrine metabolic process (GO:0042415) | 2.96931604 |
149 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.95717852 |
150 | innervation (GO:0060384) | 2.92608917 |
151 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 2.92338025 |
152 | exocrine pancreas development (GO:0031017) | 2.90783227 |
153 | auditory behavior (GO:0031223) | 2.87963813 |
154 | glutamate secretion (GO:0014047) | 2.87367702 |
155 | positive regulation of protein autophosphorylation (GO:0031954) | 2.87340771 |
156 | regulation of growth hormone secretion (GO:0060123) | 2.81814060 |
157 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.81654227 |
158 | cochlea development (GO:0090102) | 2.80429829 |
159 | response to hepatocyte growth factor (GO:0035728) | 2.79939759 |
160 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 2.79939759 |
161 | negative regulation of Ras GTPase activity (GO:0034261) | 2.75864066 |
162 | negative regulation of insulin secretion (GO:0046676) | 2.75677374 |
163 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.71116371 |
164 | * regulation of hormone secretion (GO:0046883) | 2.66431925 |
165 | neurotransmitter secretion (GO:0007269) | 2.63114471 |
166 | negative regulation of neurological system process (GO:0031645) | 2.62465352 |
167 | negative regulation of hormone metabolic process (GO:0032351) | 2.62079820 |
168 | * response to glucose (GO:0009749) | 2.60064877 |
169 | nucleoside diphosphate catabolic process (GO:0009134) | 2.59690406 |
170 | inositol phosphate catabolic process (GO:0071545) | 2.59534548 |
171 | protein targeting to Golgi (GO:0000042) | 2.56131141 |
172 | peristalsis (GO:0030432) | 2.56041339 |
173 | positive regulation of TOR signaling (GO:0032008) | 2.54924982 |
174 | * positive regulation of hormone secretion (GO:0046887) | 2.54266021 |
175 | regulation of energy homeostasis (GO:2000505) | 2.53768989 |
176 | glycerophospholipid catabolic process (GO:0046475) | 2.53756440 |
177 | cranial nerve development (GO:0021545) | 2.52367862 |
178 | regulation of oxidative phosphorylation (GO:0002082) | 2.49579562 |
179 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.48175699 |
180 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.47201533 |
181 | negative regulation of peptide hormone secretion (GO:0090278) | 2.46678553 |
182 | establishment of protein localization to Golgi (GO:0072600) | 2.46526322 |
183 | cerebellum development (GO:0021549) | 2.45549804 |
184 | neuron cell-cell adhesion (GO:0007158) | 2.45492333 |
185 | signal release (GO:0023061) | 2.44498694 |
186 | inositol phosphate dephosphorylation (GO:0046855) | 2.44451593 |
187 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.44451593 |
188 | neuromuscular process controlling posture (GO:0050884) | 2.43884327 |
189 | * response to hexose (GO:0009746) | 2.43030895 |
190 | dendritic spine organization (GO:0097061) | 2.43017400 |
191 | axonal fasciculation (GO:0007413) | 2.42089892 |
192 | * negative regulation of gluconeogenesis (GO:0045721) | 2.40882236 |
193 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.39592304 |
194 | * regulation of peptide transport (GO:0090087) | 2.37192884 |
195 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.36433877 |
196 | phenylpropanoid metabolic process (GO:0009698) | 2.36424106 |
197 | single strand break repair (GO:0000012) | 2.36096342 |
198 | neuron fate determination (GO:0048664) | 2.35818834 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.17751256 |
2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.02665059 |
3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.68895489 |
4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.40458943 |
5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.27079747 |
6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.05091950 |
7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.62683873 |
8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.06660663 |
9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.94372404 |
10 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.85172048 |
11 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.49866484 |
12 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.44097762 |
13 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.42441396 |
14 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.39986275 |
15 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.27790698 |
16 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.23656016 |
17 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.16688173 |
18 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.08073294 |
19 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.4987561 |
20 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.99011332 |
21 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.97992996 |
22 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.94038290 |
23 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.90028443 |
24 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.88061173 |
25 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.87317888 |
26 | GATA1_22025678_ChIP-Seq_K562_Human | 1.85577146 |
27 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.84912933 |
28 | P300_19829295_ChIP-Seq_ESCs_Human | 1.80844589 |
29 | * RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.77342859 |
30 | FUS_26573619_Chip-Seq_HEK293_Human | 1.74666526 |
31 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.71852717 |
32 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.69713740 |
33 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.67847057 |
34 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.67385829 |
35 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.64797837 |
36 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.64394422 |
37 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.63164109 |
38 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.61497398 |
39 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.57286438 |
40 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.55946309 |
41 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.55056120 |
42 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.54275409 |
43 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.53334452 |
44 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.51978711 |
45 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.48898789 |
46 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.48304667 |
47 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.47495850 |
48 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.46310614 |
49 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.39050573 |
50 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.38517813 |
51 | EWS_26573619_Chip-Seq_HEK293_Human | 1.38391614 |
52 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.38211249 |
53 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.36220740 |
54 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.36145803 |
55 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.35211914 |
56 | AR_25329375_ChIP-Seq_VCAP_Human | 1.34781715 |
57 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.32932207 |
58 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.32932207 |
59 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.32366809 |
60 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.29219624 |
61 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.28888112 |
62 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.28362997 |
63 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.27235519 |
64 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.26410817 |
65 | STAT3_23295773_ChIP-Seq_U87_Human | 1.26096941 |
66 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.24188375 |
67 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.24032489 |
68 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.23295927 |
69 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.19849816 |
70 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.19806655 |
71 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.19660257 |
72 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.18556645 |
73 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.18474273 |
74 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.18382317 |
75 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.16721645 |
76 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.16628936 |
77 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.15987355 |
78 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.13913290 |
79 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.13728958 |
80 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.13570686 |
81 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.11676904 |
82 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.11676904 |
83 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.11624446 |
84 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.11624446 |
85 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.11623420 |
86 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.10316599 |
87 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.09879940 |
88 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.09339094 |
89 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.08238927 |
90 | TCF4_23295773_ChIP-Seq_U87_Human | 1.07884721 |
91 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.07543170 |
92 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.07254162 |
93 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.06981854 |
94 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.06526546 |
95 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.06334645 |
96 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06311729 |
97 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.05470355 |
98 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.05041014 |
99 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.03895963 |
100 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.03852500 |
101 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.03508879 |
102 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.02733916 |
103 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.02460042 |
104 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.01698492 |
105 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.00497421 |
106 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.00269645 |
107 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.99444994 |
108 | VDR_22108803_ChIP-Seq_LS180_Human | 0.98762344 |
109 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.98416286 |
110 | TBL1_22424771_ChIP-Seq_293T_Human | 0.98048306 |
111 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.97884919 |
112 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.97631760 |
113 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.97106126 |
114 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.96689325 |
115 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.96689325 |
116 | * STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.95595746 |
117 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.94456782 |
118 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.94063283 |
119 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.94024957 |
120 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.88212283 |
121 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.85278798 |
122 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.83774065 |
123 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.82745162 |
124 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.82157612 |
125 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.81810259 |
126 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.80044153 |
127 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.77827261 |
128 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.77260464 |
129 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.76186617 |
130 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.73294320 |
131 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.71608327 |
132 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.70584458 |
133 | * KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.69477414 |
134 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.69382554 |
135 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.67060347 |
136 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.66875390 |
137 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.66672908 |
138 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.66197206 |
139 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.64407670 |
140 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.64407670 |
141 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.63910671 |
142 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.63890166 |
143 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.62225382 |
144 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.62012366 |
145 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.61773032 |
146 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.60882746 |
147 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.60745444 |
148 | AR_20517297_ChIP-Seq_VCAP_Human | 0.60169858 |
149 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.59901223 |
150 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.59271268 |
151 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.56917738 |
152 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.53625927 |
153 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.52353646 |
154 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.52300346 |
155 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.51518133 |
156 | GATA1_19941826_ChIP-Seq_K562_Human | 0.51315203 |
157 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.51044659 |
158 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.50723873 |
159 | * ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.50508943 |
160 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.49760221 |
161 | CBP_21632823_ChIP-Seq_H3396_Human | 0.49753959 |
162 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.48641838 |
163 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.47588965 |
164 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.46826019 |
165 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.46619564 |
166 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.45591176 |
167 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.45297707 |
168 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.44481981 |
169 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.42629663 |
170 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.42475063 |
171 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.41890892 |
172 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.41774463 |
173 | NCOR_22424771_ChIP-Seq_293T_Human | 0.41316563 |
174 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.40909589 |
175 | * EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.40705988 |
176 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.40494790 |
177 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.40084418 |
178 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.39820098 |
179 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.39777860 |
180 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.39213112 |
181 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.39140678 |
182 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.39140678 |
183 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.38914122 |
184 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.38726996 |
185 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.38584366 |
186 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.38121725 |
187 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.38108006 |
188 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.37888741 |
189 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.37361648 |
190 | * LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.37119242 |
191 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.36596704 |
192 | GATA2_19941826_ChIP-Seq_K562_Human | 0.35994312 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 8.34186942 |
2 | MP0005360_urolithiasis | 6.95739940 |
3 | MP0005365_abnormal_bile_salt | 6.33878054 |
4 | MP0005085_abnormal_gallbladder_physiolo | 6.32523619 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.87702422 |
6 | MP0003283_abnormal_digestive_organ | 4.29768735 |
7 | MP0003787_abnormal_imprinting | 4.28205600 |
8 | MP0003122_maternal_imprinting | 4.17123410 |
9 | MP0003806_abnormal_nucleotide_metabolis | 4.11462321 |
10 | MP0003252_abnormal_bile_duct | 3.97905822 |
11 | MP0010329_abnormal_lipoprotein_level | 3.47623976 |
12 | MP0003195_calcinosis | 3.33684727 |
13 | MP0009840_abnormal_foam_cell | 3.22621092 |
14 | MP0005083_abnormal_biliary_tract | 3.21467345 |
15 | MP0008877_abnormal_DNA_methylation | 3.10914429 |
16 | MP0003123_paternal_imprinting | 2.91252317 |
17 | MP0001666_abnormal_nutrient_absorption | 2.73701565 |
18 | MP0004270_analgesia | 2.72130786 |
19 | MP0005332_abnormal_amino_acid | 2.64904427 |
20 | MP0003121_genomic_imprinting | 2.56596686 |
21 | MP0005645_abnormal_hypothalamus_physiol | 2.29715508 |
22 | * MP0002118_abnormal_lipid_homeostasis | 2.15244652 |
23 | * MP0000609_abnormal_liver_physiology | 2.11921662 |
24 | MP0002138_abnormal_hepatobiliary_system | 2.08086339 |
25 | MP0003880_abnormal_central_pattern | 2.07756053 |
26 | MP0003191_abnormal_cellular_cholesterol | 2.07539411 |
27 | MP0003868_abnormal_feces_composition | 2.05893582 |
28 | MP0002163_abnormal_gland_morphology | 2.05035033 |
29 | MP0004859_abnormal_synaptic_plasticity | 2.00075602 |
30 | MP0004019_abnormal_vitamin_homeostasis | 1.97578288 |
31 | MP0006072_abnormal_retinal_apoptosis | 1.93883876 |
32 | MP0006276_abnormal_autonomic_nervous | 1.89264618 |
33 | MP0009046_muscle_twitch | 1.84609501 |
34 | MP0005319_abnormal_enzyme/_coenzyme | 1.76724700 |
35 | MP0001984_abnormal_olfaction | 1.74410457 |
36 | MP0001529_abnormal_vocalization | 1.73813077 |
37 | MP0008004_abnormal_stomach_pH | 1.72652474 |
38 | MP0001764_abnormal_homeostasis | 1.62780246 |
39 | MP0009745_abnormal_behavioral_response | 1.61277109 |
40 | MP0002272_abnormal_nervous_system | 1.56026336 |
41 | MP0002734_abnormal_mechanical_nocicepti | 1.54971605 |
42 | MP0003635_abnormal_synaptic_transmissio | 1.50920903 |
43 | MP0009697_abnormal_copulation | 1.49608632 |
44 | MP0001188_hyperpigmentation | 1.48838803 |
45 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.43149392 |
46 | MP0000462_abnormal_digestive_system | 1.39875900 |
47 | MP0002572_abnormal_emotion/affect_behav | 1.38466376 |
48 | MP0002064_seizures | 1.38265284 |
49 | * MP0009643_abnormal_urine_homeostasis | 1.33156855 |
50 | MP0002837_dystrophic_cardiac_calcinosis | 1.29831253 |
51 | MP0002063_abnormal_learning/memory/cond | 1.28630300 |
52 | MP0002102_abnormal_ear_morphology | 1.27795490 |
53 | MP0005220_abnormal_exocrine_pancreas | 1.27632966 |
54 | MP0000631_abnormal_neuroendocrine_gland | 1.24696514 |
55 | MP0005253_abnormal_eye_physiology | 1.24162238 |
56 | MP0002557_abnormal_social/conspecific_i | 1.23087221 |
57 | MP0005451_abnormal_body_composition | 1.19675122 |
58 | * MP0002078_abnormal_glucose_homeostasis | 1.19273857 |
59 | MP0002938_white_spotting | 1.17063635 |
60 | MP0002184_abnormal_innervation | 1.15946755 |
61 | MP0004510_myositis | 1.15508648 |
62 | MP0000778_abnormal_nervous_system | 1.14481680 |
63 | MP0001905_abnormal_dopamine_level | 1.11717107 |
64 | MP0000598_abnormal_liver_morphology | 1.11234556 |
65 | MP0003186_abnormal_redox_activity | 1.08424168 |
66 | MP0005636_abnormal_mineral_homeostasis | 1.06827338 |
67 | MP0002638_abnormal_pupillary_reflex | 1.06097340 |
68 | MP0004133_heterotaxia | 1.05839678 |
69 | MP0003119_abnormal_digestive_system | 1.05399539 |
70 | MP0001440_abnormal_grooming_behavior | 1.05038005 |
71 | MP0001970_abnormal_pain_threshold | 1.04989580 |
72 | MP0005386_behavior/neurological_phenoty | 1.04695439 |
73 | MP0004924_abnormal_behavior | 1.04695439 |
74 | MP0010386_abnormal_urinary_bladder | 1.04118174 |
75 | MP0005647_abnormal_sex_gland | 1.02160105 |
76 | MP0005551_abnormal_eye_electrophysiolog | 1.01949942 |
77 | MP0004885_abnormal_endolymph | 1.00986919 |
78 | MP0001986_abnormal_taste_sensitivity | 1.00107032 |
79 | MP0003011_delayed_dark_adaptation | 0.99513537 |
80 | MP0003656_abnormal_erythrocyte_physiolo | 0.98305252 |
81 | MP0003633_abnormal_nervous_system | 0.97685285 |
82 | MP0004811_abnormal_neuron_physiology | 0.96483341 |
83 | MP0003567_abnormal_fetal_cardiomyocyte | 0.94716594 |
84 | MP0005084_abnormal_gallbladder_morpholo | 0.94136102 |
85 | MP0010368_abnormal_lymphatic_system | 0.94091761 |
86 | MP0006036_abnormal_mitochondrial_physio | 0.94081220 |
87 | MP0000604_amyloidosis | 0.93687336 |
88 | MP0003705_abnormal_hypodermis_morpholog | 0.93412789 |
89 | MP0002069_abnormal_eating/drinking_beha | 0.93404120 |
90 | * MP0009642_abnormal_blood_homeostasis | 0.93138935 |
91 | MP0009763_increased_sensitivity_to | 0.90648568 |
92 | MP0002876_abnormal_thyroid_physiology | 0.89611245 |
93 | MP0010234_abnormal_vibrissa_follicle | 0.89471104 |
94 | MP0000955_abnormal_spinal_cord | 0.88980002 |
95 | MP0001486_abnormal_startle_reflex | 0.88707821 |
96 | MP0005670_abnormal_white_adipose | 0.88026383 |
97 | MP0005408_hypopigmentation | 0.87880602 |
98 | MP0005535_abnormal_body_temperature | 0.87654649 |
99 | MP0004085_abnormal_heartbeat | 0.85949338 |
100 | MP0005423_abnormal_somatic_nervous | 0.84816364 |
101 | MP0002229_neurodegeneration | 0.84575095 |
102 | MP0004043_abnormal_pH_regulation | 0.84207892 |
103 | MP0004145_abnormal_muscle_electrophysio | 0.83725768 |
104 | MP0005334_abnormal_fat_pad | 0.83193123 |
105 | * MP0001944_abnormal_pancreas_morphology | 0.82948878 |
106 | MP0001968_abnormal_touch/_nociception | 0.82904589 |
107 | MP0000516_abnormal_urinary_system | 0.82711350 |
108 | MP0005367_renal/urinary_system_phenotyp | 0.82711350 |
109 | MP0002882_abnormal_neuron_morphology | 0.81930061 |
110 | MP0002733_abnormal_thermal_nociception | 0.81634289 |
111 | MP0009764_decreased_sensitivity_to | 0.81281920 |
112 | MP0002067_abnormal_sensory_capabilities | 0.79922948 |
113 | MP0002735_abnormal_chemical_nociception | 0.78480742 |
114 | MP0002971_abnormal_brown_adipose | 0.78147932 |
115 | MP0001502_abnormal_circadian_rhythm | 0.78088056 |
116 | MP0003879_abnormal_hair_cell | 0.77827338 |
117 | MP0001661_extended_life_span | 0.77361852 |
118 | * MP0008469_abnormal_protein_level | 0.77042405 |
119 | MP0004130_abnormal_muscle_cell | 0.76801213 |
120 | MP0000003_abnormal_adipose_tissue | 0.75716620 |
121 | MP0005376_homeostasis/metabolism_phenot | 0.74841390 |
122 | MP0005448_abnormal_energy_balance | 0.74754193 |
123 | MP0002066_abnormal_motor_capabilities/c | 0.73771562 |
124 | MP0002254_reproductive_system_inflammat | 0.72453301 |
125 | MP0001756_abnormal_urination | 0.72092446 |
126 | * MP0002693_abnormal_pancreas_physiology | 0.71647238 |
127 | MP0002928_abnormal_bile_duct | 0.70533981 |
128 | MP0004142_abnormal_muscle_tone | 0.69844283 |
129 | MP0000639_abnormal_adrenal_gland | 0.69596830 |
130 | MP0004215_abnormal_myocardial_fiber | 0.69170642 |
131 | MP0009765_abnormal_xenobiotic_induced | 0.67505323 |
132 | MP0005266_abnormal_metabolism | 0.67496590 |
133 | * MP0003953_abnormal_hormone_level | 0.65725974 |
134 | MP0003329_amyloid_beta_deposits | 0.62379746 |
135 | MP0002909_abnormal_adrenal_gland | 0.60117545 |
136 | MP0009780_abnormal_chondrocyte_physiolo | 0.59592183 |
137 | MP0005379_endocrine/exocrine_gland_phen | 0.55759944 |
138 | MP0006035_abnormal_mitochondrial_morpho | 0.55255121 |
139 | MP0003690_abnormal_glial_cell | 0.53316754 |
140 | MP0009672_abnormal_birth_weight | 0.50562451 |
141 | MP0004264_abnormal_extraembryonic_tissu | 0.50560560 |
142 | MP0003959_abnormal_lean_body | 0.47766584 |
143 | MP0000230_abnormal_systemic_arterial | 0.45832526 |
144 | MP0009053_abnormal_anal_canal | 0.43014956 |
145 | MP0002822_catalepsy | 0.42968307 |
146 | MP0002877_abnormal_melanocyte_morpholog | 0.41844513 |
147 | MP0005395_other_phenotype | 0.41194092 |
148 | MP0003638_abnormal_response/metabolism_ | 0.41182450 |
149 | MP0002970_abnormal_white_adipose | 0.39846503 |
150 | MP0004782_abnormal_surfactant_physiolog | 0.39577959 |
151 | MP0002136_abnormal_kidney_physiology | 0.38267557 |
152 | MP0005666_abnormal_adipose_tissue | 0.37982174 |
153 | MP0000579_abnormal_nail_morphology | 0.36913375 |
154 | MP0001765_abnormal_ion_homeostasis | 0.36671262 |
155 | MP0005248_abnormal_Harderian_gland | 0.36140376 |
156 | MP0000013_abnormal_adipose_tissue | 0.35818883 |
157 | MP0002168_other_aberrant_phenotype | 0.35451865 |
158 | MP0005646_abnormal_pituitary_gland | 0.35020389 |
159 | MP0002269_muscular_atrophy | 0.34904233 |
160 | MP0005187_abnormal_penis_morphology | 0.33824940 |
161 | MP0005058_abnormal_lysosome_morphology | 0.33823009 |
162 | MP0008873_increased_physiological_sensi | 0.33568767 |
163 | MP0008961_abnormal_basal_metabolism | 0.32328359 |
164 | MP0008874_decreased_physiological_sensi | 0.32264321 |
165 | MP0005464_abnormal_platelet_physiology | 0.31435981 |
166 | MP0003724_increased_susceptibility_to | 0.29309939 |
167 | MP0002090_abnormal_vision | 0.28415281 |
168 | MP0005452_abnormal_adipose_tissue | 0.28336295 |
169 | MP0003075_altered_response_to | 0.27727046 |
170 | MP0009115_abnormal_fat_cell | 0.26966068 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.58229810 |
2 | Intrahepatic cholestasis (HP:0001406) | 7.13435140 |
3 | Deep venous thrombosis (HP:0002625) | 6.92254091 |
4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.46940597 |
5 | Prolonged partial thromboplastin time (HP:0003645) | 6.38056515 |
6 | Hypobetalipoproteinemia (HP:0003563) | 6.21341910 |
7 | Xanthomatosis (HP:0000991) | 6.10827414 |
8 | Hyperlipoproteinemia (HP:0010980) | 5.28378398 |
9 | Complement deficiency (HP:0004431) | 5.06346390 |
10 | Hypolipoproteinemia (HP:0010981) | 4.60082154 |
11 | Abnormality of the common coagulation pathway (HP:0010990) | 4.54520909 |
12 | Joint hemorrhage (HP:0005261) | 4.48425471 |
13 | Insulin-resistant diabetes mellitus (HP:0000831) | 4.45586380 |
14 | * Ketosis (HP:0001946) | 4.43516532 |
15 | Epidermoid cyst (HP:0200040) | 4.37746123 |
16 | * Abnormality of endocrine pancreas physiology (HP:0012093) | 4.37650843 |
17 | * Abnormality of the pancreatic islet cells (HP:0006476) | 4.37650843 |
18 | * Hypoglycemic coma (HP:0001325) | 4.36387706 |
19 | Hyperglycinemia (HP:0002154) | 4.33666052 |
20 | Hyperammonemia (HP:0001987) | 4.32997686 |
21 | Abnormality of the intrinsic pathway (HP:0010989) | 4.22195584 |
22 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.17103436 |
23 | Fat malabsorption (HP:0002630) | 4.14831334 |
24 | Conjugated hyperbilirubinemia (HP:0002908) | 4.08595646 |
25 | Hypoalphalipoproteinemia (HP:0003233) | 3.98744225 |
26 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.97363571 |
27 | Abnormality of methionine metabolism (HP:0010901) | 3.89013000 |
28 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.87477421 |
29 | Hyperglycinuria (HP:0003108) | 3.81102121 |
30 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.73158560 |
31 | Abnormality of glycine metabolism (HP:0010895) | 3.73158560 |
32 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.71527277 |
33 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.69423309 |
34 | Abnormal pancreas size (HP:0012094) | 3.69061235 |
35 | Abnormality of complement system (HP:0005339) | 3.64960064 |
36 | Agitation (HP:0000713) | 3.62927259 |
37 | Hepatoblastoma (HP:0002884) | 3.61011706 |
38 | Large for gestational age (HP:0001520) | 3.56610618 |
39 | * EEG with generalized epileptiform discharges (HP:0011198) | 3.56567114 |
40 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.54045649 |
41 | * Epileptiform EEG discharges (HP:0011182) | 3.50258918 |
42 | * Hypsarrhythmia (HP:0002521) | 3.45503634 |
43 | * Ketoacidosis (HP:0001993) | 3.42191975 |
44 | Hyperbilirubinemia (HP:0002904) | 3.39402369 |
45 | * Prominent metopic ridge (HP:0005487) | 3.38128153 |
46 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.37052278 |
47 | Hypercholesterolemia (HP:0003124) | 3.36837483 |
48 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.36459377 |
49 | Enlarged penis (HP:0000040) | 3.32178725 |
50 | * Abnormality of the metopic suture (HP:0005556) | 3.10366715 |
51 | Poor suck (HP:0002033) | 3.09512747 |
52 | Skin nodule (HP:0200036) | 3.07346941 |
53 | Steatorrhea (HP:0002570) | 3.04329911 |
54 | Abnormality of nucleobase metabolism (HP:0010932) | 3.04076901 |
55 | Hypomagnesemia (HP:0002917) | 3.00113810 |
56 | * Hypoglycemic seizures (HP:0002173) | 2.97785365 |
57 | Hypothermia (HP:0002045) | 2.94465629 |
58 | Delayed CNS myelination (HP:0002188) | 2.88592249 |
59 | Abnormality of purine metabolism (HP:0004352) | 2.87885663 |
60 | Intestinal atresia (HP:0011100) | 2.83313866 |
61 | Abnormality of serum amino acid levels (HP:0003112) | 2.83267841 |
62 | * Hyperinsulinemic hypoglycemia (HP:0000825) | 2.80999813 |
63 | Gout (HP:0001997) | 2.79098281 |
64 | Metabolic acidosis (HP:0001942) | 2.77670537 |
65 | Hepatocellular carcinoma (HP:0001402) | 2.77198425 |
66 | Spontaneous abortion (HP:0005268) | 2.69342322 |
67 | Myocardial infarction (HP:0001658) | 2.68938567 |
68 | Dicarboxylic aciduria (HP:0003215) | 2.68309765 |
69 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.68309765 |
70 | Hypochromic microcytic anemia (HP:0004840) | 2.66023844 |
71 | * Muscular hypotonia of the trunk (HP:0008936) | 2.63398609 |
72 | Lethargy (HP:0001254) | 2.59401032 |
73 | Abnormal gallbladder morphology (HP:0012437) | 2.59076119 |
74 | Generalized aminoaciduria (HP:0002909) | 2.58245741 |
75 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.58052037 |
76 | Irritability (HP:0000737) | 2.50607026 |
77 | Mitral stenosis (HP:0001718) | 2.49434980 |
78 | Cerebral edema (HP:0002181) | 2.48580835 |
79 | Increased circulating renin level (HP:0000848) | 2.47073469 |
80 | Double outlet right ventricle (HP:0001719) | 2.46939203 |
81 | Congenital malformation of the right heart (HP:0011723) | 2.46939203 |
82 | Systemic lupus erythematosus (HP:0002725) | 2.46906601 |
83 | Testicular neoplasm (HP:0010788) | 2.42179211 |
84 | Polyphagia (HP:0002591) | 2.40381505 |
85 | Cholelithiasis (HP:0001081) | 2.38001440 |
86 | Acanthocytosis (HP:0001927) | 2.36762492 |
87 | Type I diabetes mellitus (HP:0100651) | 2.34893999 |
88 | Abnormality of the labia minora (HP:0012880) | 2.33889054 |
89 | Hyperphosphatemia (HP:0002905) | 2.33318059 |
90 | Cholecystitis (HP:0001082) | 2.30558858 |
91 | Abnormal gallbladder physiology (HP:0012438) | 2.30558858 |
92 | Abnormality of magnesium homeostasis (HP:0004921) | 2.29384448 |
93 | Medial flaring of the eyebrow (HP:0010747) | 2.29341783 |
94 | * Hyperglycemia (HP:0003074) | 2.28855705 |
95 | Brushfield spots (HP:0001088) | 2.28603386 |
96 | Hyperthyroidism (HP:0000836) | 2.28163544 |
97 | Vascular calcification (HP:0004934) | 2.27261429 |
98 | Enlarged kidneys (HP:0000105) | 2.24558182 |
99 | * Late onset (HP:0003584) | 2.24401533 |
100 | Pancreatitis (HP:0001733) | 2.23874922 |
101 | Glomerulonephritis (HP:0000099) | 2.21392443 |
102 | Hemiparesis (HP:0001269) | 2.20877444 |
103 | Neonatal onset (HP:0003623) | 2.18107927 |
104 | Myokymia (HP:0002411) | 2.17022555 |
105 | * Symptomatic seizures (HP:0011145) | 2.14460945 |
106 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.12890193 |
107 | Unilateral renal agenesis (HP:0000122) | 2.11846088 |
108 | Intention tremor (HP:0002080) | 2.11537121 |
109 | Menstrual irregularities (HP:0000858) | 2.11172723 |
110 | Epileptic encephalopathy (HP:0200134) | 2.10972836 |
111 | Malnutrition (HP:0004395) | 2.10405280 |
112 | Sensorimotor neuropathy (HP:0007141) | 2.10361033 |
113 | Abnormal drinking behavior (HP:0030082) | 2.09938744 |
114 | Polydipsia (HP:0001959) | 2.09938744 |
115 | Spastic diplegia (HP:0001264) | 2.09930325 |
116 | Vomiting (HP:0002013) | 2.08105513 |
117 | Abnormality of the gallbladder (HP:0005264) | 2.07266979 |
118 | Abnormal sex determination (HP:0012244) | 2.06915318 |
119 | Sex reversal (HP:0012245) | 2.06915318 |
120 | Menorrhagia (HP:0000132) | 2.06432201 |
121 | Opisthotonus (HP:0002179) | 2.06011705 |
122 | Macroorchidism (HP:0000053) | 2.04959784 |
123 | Amyloidosis (HP:0011034) | 2.04698743 |
124 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.02652396 |
125 | Restlessness (HP:0000711) | 1.99548802 |
126 | Cardiovascular calcification (HP:0011915) | 1.98586326 |
127 | Gait imbalance (HP:0002141) | 1.98044072 |
128 | Neoplasm of the adrenal cortex (HP:0100641) | 1.97551839 |
129 | Esophageal varix (HP:0002040) | 1.95477295 |
130 | Renal cortical cysts (HP:0000803) | 1.95404260 |
131 | Anxiety (HP:0000739) | 1.93792132 |
132 | Hypogonadotrophic hypogonadism (HP:0000044) | 1.93496800 |
133 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.92854762 |
134 | Nephrogenic diabetes insipidus (HP:0009806) | 1.92043435 |
135 | Febrile seizures (HP:0002373) | 1.91934794 |
136 | Gingival bleeding (HP:0000225) | 1.91903440 |
137 | Nephronophthisis (HP:0000090) | 1.91597507 |
138 | Abnormality of urine glucose concentration (HP:0011016) | 1.91135884 |
139 | Glycosuria (HP:0003076) | 1.91135884 |
140 | Acute hepatic failure (HP:0006554) | 1.90421912 |
141 | Aqueductal stenosis (HP:0002410) | 1.88682082 |
142 | Methylmalonic acidemia (HP:0002912) | 1.88368678 |
143 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.87465785 |
144 | Rickets (HP:0002748) | 1.86532783 |
145 | Congenital primary aphakia (HP:0007707) | 1.84171916 |
146 | Alkalosis (HP:0001948) | 1.83021114 |
147 | Abnormal cartilage morphology (HP:0002763) | 1.82355774 |
148 | Amblyopia (HP:0000646) | 1.81666284 |
149 | Septate vagina (HP:0001153) | 1.81636282 |
150 | Thrombophlebitis (HP:0004418) | 1.81579583 |
151 | Abnormality of iron homeostasis (HP:0011031) | 1.81465278 |
152 | * Downturned corners of mouth (HP:0002714) | 1.81400992 |
153 | Hemorrhage of the eye (HP:0011885) | 1.80777131 |
154 | Progressive macrocephaly (HP:0004481) | 1.80576691 |
155 | * Insulin resistance (HP:0000855) | 1.80494288 |
156 | Poikilocytosis (HP:0004447) | 1.79173828 |
157 | Dialeptic seizures (HP:0011146) | 1.79030892 |
158 | Failure to thrive in infancy (HP:0001531) | 1.78322823 |
159 | 3-Methylglutaconic aciduria (HP:0003535) | 1.77995419 |
160 | Elevated alkaline phosphatase (HP:0003155) | 1.77590081 |
161 | Elevated hepatic transaminases (HP:0002910) | 1.76393599 |
162 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.74098526 |
163 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.74098526 |
164 | Limb dystonia (HP:0002451) | 1.73329018 |
165 | Labial hypoplasia (HP:0000066) | 1.71289418 |
166 | Akinesia (HP:0002304) | 1.71124873 |
167 | Progressive cerebellar ataxia (HP:0002073) | 1.70692696 |
168 | Neoplasm of the adrenal gland (HP:0100631) | 1.70146577 |
169 | Diminished movement (HP:0002374) | 1.69601110 |
170 | Hyperphosphaturia (HP:0003109) | 1.68410438 |
171 | Gaze-evoked nystagmus (HP:0000640) | 1.66454863 |
172 | Thyroid carcinoma (HP:0002890) | 1.65571226 |
173 | Neoplasm of the heart (HP:0100544) | 1.63721708 |
174 | Hepatic necrosis (HP:0002605) | 1.63436726 |
175 | Hamartoma of the eye (HP:0010568) | 1.62870291 |
176 | Abnormal eating behavior (HP:0100738) | 1.61185337 |
177 | Pancreatic fibrosis (HP:0100732) | 1.60891801 |
178 | Focal seizures (HP:0007359) | 1.59977121 |
179 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.59894335 |
180 | Villous atrophy (HP:0011473) | 1.59894335 |
181 | Hypokinesia (HP:0002375) | 1.59326967 |
182 | Ventricular fibrillation (HP:0001663) | 1.58104802 |
183 | Genital tract atresia (HP:0001827) | 1.56761105 |
184 | Hypoplastic female external genitalia (HP:0012815) | 1.52040728 |
185 | Absence seizures (HP:0002121) | 1.49847530 |
186 | Generalized tonic-clonic seizures (HP:0002069) | 1.49559019 |
187 | Chronic hepatic failure (HP:0100626) | 1.49417730 |
188 | Abnormality of vitamin B metabolism (HP:0004340) | 1.47995049 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 6.47392311 |
2 | INSRR | 5.05470403 |
3 | ERN1 | 4.49297697 |
4 | SIK1 | 4.27939999 |
5 | TRIM28 | 4.10299377 |
6 | FGFR4 | 3.92320796 |
7 | TAOK3 | 3.79985872 |
8 | CASK | 2.86045872 |
9 | MAPK15 | 2.70485871 |
10 | FLT3 | 2.45027176 |
11 | ERBB4 | 2.41308879 |
12 | NTRK3 | 2.33205320 |
13 | BCR | 2.28846273 |
14 | PIK3CG | 2.23818754 |
15 | FRK | 2.17161454 |
16 | PKN2 | 2.09528662 |
17 | MAP3K4 | 2.06837286 |
18 | TNIK | 2.05408819 |
19 | TRIB3 | 2.04497418 |
20 | PHKG1 | 1.98672170 |
21 | PHKG2 | 1.98672170 |
22 | MAP4K2 | 1.82003195 |
23 | MAP2K4 | 1.79800426 |
24 | MARK1 | 1.74331193 |
25 | PTK6 | 1.56409288 |
26 | MST1R | 1.50393362 |
27 | DYRK2 | 1.48289075 |
28 | CSNK1G3 | 1.47592405 |
29 | CSNK1G2 | 1.46855175 |
30 | ERBB3 | 1.44528305 |
31 | MAPK11 | 1.44353197 |
32 | DAPK2 | 1.39968737 |
33 | MST4 | 1.35899534 |
34 | LATS1 | 1.33695551 |
35 | MAP2K7 | 1.32144475 |
36 | UHMK1 | 1.26592157 |
37 | EPHA3 | 1.21241145 |
38 | ADRBK2 | 1.20324037 |
39 | PLK3 | 1.16091645 |
40 | JAK2 | 1.14763309 |
41 | GRK1 | 1.12736345 |
42 | TSSK6 | 1.12505432 |
43 | TYK2 | 1.11944209 |
44 | PINK1 | 1.11896006 |
45 | NLK | 1.11695944 |
46 | PASK | 1.09362317 |
47 | CSNK1A1L | 1.08490351 |
48 | DYRK1B | 1.03621181 |
49 | PRKAA2 | 1.00534306 |
50 | MET | 0.98053224 |
51 | ABL2 | 0.96897026 |
52 | PLK2 | 0.96726188 |
53 | MINK1 | 0.95912530 |
54 | IRAK3 | 0.93545130 |
55 | NEK9 | 0.93109589 |
56 | MAP3K3 | 0.87830867 |
57 | JAK1 | 0.87333891 |
58 | MAP3K1 | 0.83921812 |
59 | MAP3K2 | 0.83711399 |
60 | MAP3K7 | 0.83286030 |
61 | PRKAA1 | 0.83250091 |
62 | KDR | 0.82101581 |
63 | FGFR2 | 0.81767099 |
64 | LMTK2 | 0.81598876 |
65 | MKNK2 | 0.81592346 |
66 | PTK2 | 0.79368924 |
67 | WNK3 | 0.78855485 |
68 | PRKACG | 0.78819721 |
69 | MAP3K9 | 0.78057139 |
70 | STK16 | 0.77394149 |
71 | NUAK1 | 0.75940838 |
72 | NTRK2 | 0.75228628 |
73 | CDK5 | 0.74297003 |
74 | STK38L | 0.73435124 |
75 | ERBB2 | 0.72366329 |
76 | TBK1 | 0.71929919 |
77 | DYRK3 | 0.71733863 |
78 | PRKCZ | 0.71380512 |
79 | PRKCE | 0.70798043 |
80 | CAMK2D | 0.70273104 |
81 | PNCK | 0.69898762 |
82 | EPHB1 | 0.68494580 |
83 | TESK1 | 0.68242902 |
84 | GSK3A | 0.67098180 |
85 | STK3 | 0.66143365 |
86 | CAMK2G | 0.65865457 |
87 | PAK3 | 0.65291024 |
88 | MAP2K3 | 0.65017815 |
89 | HIPK2 | 0.63533717 |
90 | STK38 | 0.63021676 |
91 | TIE1 | 0.62555639 |
92 | MAP3K10 | 0.61359719 |
93 | RIPK1 | 0.60383890 |
94 | ACVR1B | 0.60184918 |
95 | CAMK2A | 0.59279622 |
96 | MAPK4 | 0.59183734 |
97 | RET | 0.58466430 |
98 | CAMK1D | 0.57607607 |
99 | WNK4 | 0.56965605 |
100 | STK24 | 0.56887244 |
101 | PDGFRA | 0.55551590 |
102 | CSNK1A1 | 0.54634382 |
103 | DAPK1 | 0.53791706 |
104 | OXSR1 | 0.53026752 |
105 | DYRK1A | 0.52882612 |
106 | IRAK1 | 0.51952252 |
107 | CSK | 0.51488170 |
108 | CSNK1E | 0.49924218 |
109 | MAP2K6 | 0.48941874 |
110 | MAP2K1 | 0.47763719 |
111 | SGK3 | 0.47730004 |
112 | MAP2K2 | 0.47437716 |
113 | PDPK1 | 0.46940463 |
114 | IRAK2 | 0.46133019 |
115 | MAPK13 | 0.46127329 |
116 | MTOR | 0.46045419 |
117 | BMPR1B | 0.45769416 |
118 | ZAK | 0.45658414 |
119 | PRKG1 | 0.45215637 |
120 | FGFR3 | 0.45060200 |
121 | NTRK1 | 0.44603417 |
122 | IGF1R | 0.43829324 |
123 | PRKCH | 0.43635701 |
124 | PIK3CA | 0.43520945 |
125 | MAP3K11 | 0.43286151 |
126 | MAP3K6 | 0.40592967 |
127 | MAP3K14 | 0.40357987 |
128 | SGK2 | 0.40356605 |
129 | OBSCN | 0.39691618 |
130 | CSNK1D | 0.39531772 |
131 | ALK | 0.39034876 |
132 | PRKCG | 0.38959228 |
133 | AKT3 | 0.38509928 |
134 | MAPK12 | 0.37027471 |
135 | PRKDC | 0.36901941 |
136 | CAMK2B | 0.36866734 |
137 | PAK6 | 0.36601385 |
138 | CAMK1 | 0.36413630 |
139 | STK39 | 0.35990097 |
140 | MAP3K5 | 0.35904371 |
141 | LIMK1 | 0.35845615 |
142 | SRPK1 | 0.34684602 |
143 | STK4 | 0.33573806 |
144 | CDK14 | 0.31569250 |
145 | SGK223 | 0.31434697 |
146 | SGK494 | 0.31434697 |
147 | ATM | 0.31237552 |
148 | STK11 | 0.30163128 |
149 | MAPK9 | 0.29949288 |
150 | PRKCQ | 0.29700669 |
151 | GRK6 | 0.29645842 |
152 | CSNK1G1 | 0.28945826 |
153 | PRKG2 | 0.28701589 |
154 | MAPK7 | 0.28682501 |
155 | CDK6 | 0.28456547 |
156 | PRKCA | 0.28114649 |
157 | PRKACA | 0.27804042 |
158 | PKN1 | 0.27647988 |
159 | PRKD1 | 0.26994633 |
160 | CAMK4 | 0.24681795 |
161 | PDK1 | 0.24234244 |
162 | CAMK1G | 0.23899867 |
163 | ZAP70 | 0.22780813 |
164 | FER | 0.22638987 |
165 | ITK | 0.22437762 |
166 | ICK | 0.21514795 |
167 | EGFR | 0.19734725 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.42778416 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.30041317 |
3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.25554186 |
4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.21918697 |
5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.87789136 |
6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.82686332 |
7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.63924189 |
8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.61430669 |
9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.56225560 |
10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.53934052 |
11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.51287711 |
12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.41915662 |
13 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.26472039 |
14 | * Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.18378759 |
15 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.17845978 |
16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.16043455 |
17 | Peroxisome_Homo sapiens_hsa04146 | 2.08607151 |
18 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.97012712 |
19 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.92343213 |
20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.91229380 |
21 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.88283693 |
22 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.86611862 |
23 | Nicotine addiction_Homo sapiens_hsa05033 | 1.86141279 |
24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.84274430 |
25 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.82780821 |
26 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.79395264 |
27 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.78179310 |
28 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.78009162 |
29 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.77163521 |
30 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.65320742 |
31 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.65298285 |
32 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.61464571 |
33 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.60512800 |
34 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.60205642 |
35 | Retinol metabolism_Homo sapiens_hsa00830 | 1.59953957 |
36 | GABAergic synapse_Homo sapiens_hsa04727 | 1.57965947 |
37 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.56796023 |
38 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.56332273 |
39 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.56239683 |
40 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.50919913 |
41 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.48460197 |
42 | Bile secretion_Homo sapiens_hsa04976 | 1.47554387 |
43 | Cocaine addiction_Homo sapiens_hsa05030 | 1.45347119 |
44 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.45077884 |
45 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.39379853 |
46 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.38197021 |
47 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.36727141 |
48 | Phototransduction_Homo sapiens_hsa04744 | 1.34129368 |
49 | ABC transporters_Homo sapiens_hsa02010 | 1.31898901 |
50 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.31753129 |
51 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.29367531 |
52 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.25066380 |
53 | * Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.23336065 |
54 | Circadian entrainment_Homo sapiens_hsa04713 | 1.21340984 |
55 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.20206587 |
56 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.17308980 |
57 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.17270045 |
58 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.14456209 |
59 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.10564842 |
60 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.09347447 |
61 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.08026852 |
62 | * Carbon metabolism_Homo sapiens_hsa01200 | 1.05381371 |
63 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.02312144 |
64 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.01621387 |
65 | Morphine addiction_Homo sapiens_hsa05032 | 1.01231874 |
66 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.00505019 |
67 | Taste transduction_Homo sapiens_hsa04742 | 0.99687252 |
68 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.97026225 |
69 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.91865498 |
70 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.91162878 |
71 | Sulfur relay system_Homo sapiens_hsa04122 | 0.90548415 |
72 | Long-term depression_Homo sapiens_hsa04730 | 0.90097032 |
73 | Lysine degradation_Homo sapiens_hsa00310 | 0.86788433 |
74 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.85368385 |
75 | Renin secretion_Homo sapiens_hsa04924 | 0.84688425 |
76 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.84572205 |
77 | Parkinsons disease_Homo sapiens_hsa05012 | 0.84447614 |
78 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.80924464 |
79 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.79395097 |
80 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.78249684 |
81 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.77754546 |
82 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.77597747 |
83 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.74408267 |
84 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.72611563 |
85 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.72338214 |
86 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.71426864 |
87 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.70309742 |
88 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.68198852 |
89 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.67273673 |
90 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.66228978 |
91 | * Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.61861504 |
92 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.61692720 |
93 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.59709330 |
94 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.59617611 |
95 | Alzheimers disease_Homo sapiens_hsa05010 | 0.52663390 |
96 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.52245388 |
97 | Prion diseases_Homo sapiens_hsa05020 | 0.50695072 |
98 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.50352651 |
99 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.50200881 |
100 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.47837854 |
101 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.47646804 |
102 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.45981434 |
103 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.45414589 |
104 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.44575759 |
105 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.44465715 |
106 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.43627728 |
107 | Salivary secretion_Homo sapiens_hsa04970 | 0.42282586 |
108 | Basal transcription factors_Homo sapiens_hsa03022 | 0.42230547 |
109 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.39208001 |
110 | Insulin resistance_Homo sapiens_hsa04931 | 0.38816289 |
111 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.37896827 |
112 | RNA polymerase_Homo sapiens_hsa03020 | 0.37534489 |
113 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.37327992 |
114 | Protein export_Homo sapiens_hsa03060 | 0.37113963 |
115 | Huntingtons disease_Homo sapiens_hsa05016 | 0.35634007 |
116 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.34884050 |
117 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.32638244 |
118 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.31221605 |
119 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.27705722 |
120 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.27345870 |
121 | * Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.20574697 |
122 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.18060019 |
123 | * Galactose metabolism_Homo sapiens_hsa00052 | 0.14710475 |
124 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.13463298 |
125 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.09536249 |
126 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.09194849 |
127 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.04287232 |
128 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.02699250 |
129 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.2077197 |
130 | Bladder cancer_Homo sapiens_hsa05219 | -0.2029765 |
131 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.1818993 |
132 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1682028 |
133 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.1580475 |
134 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.1510377 |
135 | Lysosome_Homo sapiens_hsa04142 | -0.1297591 |
136 | * Insulin secretion_Homo sapiens_hsa04911 | -0.1183896 |
137 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1161668 |
138 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0943614 |
139 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.0938150 |
140 | * Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0833377 |
141 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0621618 |
142 | * Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.0540868 |
143 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0407926 |
144 | * Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0357826 |
145 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0072092 |